Gyeonggi-do
South Korea
7
2021-04-22
6
2023-03-14
These are the the leading inventors for applications assigned to CrystalGenomics, Inc.:
CrystalGenomics, Inc. based in Gyeonggi-do, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pharmaceutical composition, comprising polmacoxib and pregabalin, for treatment of pain
#2 | 2021-01-14 ✅ Patent 11,230,539 granted on 2022-01-252,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including same
#3 | 2020-09-10 ✅ Patent 11,655,207 granted on 2023-05-23Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxy amide or of derivative thereof and method for preparing same
#4 | 2018-12-06METHODS FOR TREATING PATIENTS WITH HEMATOLOGIC MALIGNANCIES
#5 | 2018-01-11 ✅ Patent 10,413,520 granted on 2019-09-17Oral pharmacological composition including 5-{4-(amino sulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone having crystalline structure with excellent stability
#6 | 2017-12-21 ✅ Patent 10,604,508 granted on 2020-03-312,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including same
#7 | 2015-11-26 ✅ Patent 9,758,508 granted on 2017-09-122,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including same
Also check out CrystalGenomics, Inc.'s (Gyeonggi-do, South Korea) applicant profile with 7 patent applications submitted.
142344 ⎘